BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 15814293)

  • 1. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohematological surveillance of the pregnant woman: new prevention policy].
    Mannessier L
    Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
    Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):476-94. PubMed ID: 5000274
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-level rhesus alloimmunization and other alloimmunizations in pregnancy].
    Pellet B; Chessex D; Schneider P; Holfeld P
    Rev Med Suisse Romande; 1991 Aug; 111(8):693-9. PubMed ID: 1925243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 69.